Mary E Lebsack
Impact in
- Rheumatology top 5%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Hematology top 10%
- Autoimmune and Inflammatory Disorders Research
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Drug-Induced Hepatotoxicity and Protection 1
-
- Antibiotic Resistance in Bacteria 2
- Co-authors
- G. Campion (1 shared paper)Gary V. Gordon (1 shared paper)Janice L. Lookabaugh (1 shared paper)Joan M Korth-Bradley (1 shared paper)Roberta K Hanna (1 shared paper)Abbe Sue Rubin (1 shared paper)Donna K. Simcoe (1 shared paper)Allen J. Sedman (6 shared papers)
- Journals
- The Journal of Clinical Pharmacology (3 papers)Antimicrobial Agents and Chemotherapy (2 papers)Journal of Clinical Oncology (2 papers)Annals of Pharmacotherapy (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesCanada
In The Last Decade
Mary E Lebsack
11 papers receiving 464 citations
Peers
Comparison fields: 5 of 68
- Rheumatology 172
- Hematology 97
- Pharmacology 100
- Immunology 110
- Molecular Medicine 26
Countries citing papers authored by Mary E Lebsack
This map shows the geographic impact of Mary E Lebsack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E Lebsack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E Lebsack more than expected).
Fields of papers citing papers by Mary E Lebsack
This network shows the impact of papers produced by Mary E Lebsack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E Lebsack. The network helps show where Mary E Lebsack may publish in the future.
Co-authors
The 25 scholars most cited alongside Mary E Lebsack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 217 | |
| 2 | 2000 | 130 | |
| 3 | 1989 | 92 | |
| 4 | 1992 | 32 | |
| 5 | Safety of FLT3 ligand in healthy volunteers | 1997 | 17 |
| 6 | 1997 | 15 | |
| 7 | 1996 | 10 | |
| 8 | 1993 | 7 | |
| 9 | 1988 | 6 | |
| 10 | 1991 | 2 | |
| 11 | 1992 | 2 |
About Mary E Lebsack
Mary E Lebsack is a scholar working on Pharmacology, Molecular Medicine, Emergency Medicine, Pharmacology and Analytical Chemistry, having authored 11 papers that have together received 530 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Analytical Methods in Pharmaceuticals (2 papers), Poisoning and overdose treatments (2 papers), Antibiotic Resistance in Bacteria (2 papers), Acute Myeloid Leukemia Research (1 paper), Drug-Induced Hepatotoxicity and Protection (1 paper), Chronic Myeloid Leukemia Treatments (1 paper) and Rheumatoid Arthritis Research and Therapies (1 paper). The work is most often cited by research in Rheumatology (172 citations), Hematology (97 citations), Pharmacology (100 citations), Immunology (110 citations) and Molecular Medicine (26 citations). Mary E Lebsack has collaborated with scholars based in United States and Canada. Frequent co-authors include G. Campion, Gary V. Gordon, Janice L. Lookabaugh, Joan M Korth-Bradley, Roberta K Hanna, Abbe Sue Rubin, Donna K. Simcoe, Allen J. Sedman, Jerome J. Schentag and John H. Wilton. Their work appears in journals such as The Journal of Clinical Pharmacology, Antimicrobial Agents and Chemotherapy, Journal of Clinical Oncology, Annals of Pharmacotherapy and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.